Northern Oak Wealth Management Inc. trimmed its stake in Colgate-Palmolive (NYSE:CL) by 12.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,046 shares of the company’s stock after selling 1,193 shares during the period. Northern Oak Wealth Management Inc.’s holdings in Colgate-Palmolive were worth $586,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Blue Chip Partners Inc. grew its position in Colgate-Palmolive by 0.4% during the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after purchasing an additional 8 shares during the last quarter. AlphaMark Advisors LLC grew its position in Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the last quarter. Weatherstone Capital Management grew its position in Colgate-Palmolive by 0.7% during the 2nd quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock worth $302,000 after purchasing an additional 28 shares during the last quarter. Dorsey & Whitney Trust CO LLC grew its position in Colgate-Palmolive by 0.6% during the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock worth $419,000 after purchasing an additional 34 shares during the last quarter. Finally, Jackson Grant Investment Advisers Inc. grew its position in Colgate-Palmolive by 0.5% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 7,028 shares of the company’s stock worth $521,000 after purchasing an additional 35 shares during the last quarter. 72.86% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Colgate-Palmolive (NYSE CL) opened at $77.50 on Friday. The firm has a market cap of $68,053.13, a PE ratio of 27.00, a PEG ratio of 3.24 and a beta of 0.80. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a fifty-two week low of $63.43 and a fifty-two week high of $77.91.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.73. The business had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.73 earnings per share. sell-side analysts expect that Colgate-Palmolive will post 2.87 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.06%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s payout ratio is 61.78%.

In related news, Director Stephen I. Sadove sold 20,780 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total value of $1,465,405.60. Following the completion of the sale, the director now owns 36,268 shares in the company, valued at $2,557,619.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total transaction of $68,389.64. Following the completion of the sale, the insider now owns 37,788 shares of the company’s stock, valued at approximately $2,865,086.16. The disclosure for this sale can be found here. In the last ninety days, insiders sold 181,950 shares of company stock worth $13,237,385. Insiders own 1.02% of the company’s stock.

Several brokerages have issued reports on CL. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their price objective for the stock from $65.00 to $85.00 in a research report on Wednesday, October 11th. Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective on the stock. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Citigroup lowered their price objective on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research report on Thursday, November 2nd. Finally, Stifel Nicolaus set a $73.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday, October 29th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $76.45.

WARNING: “Colgate-Palmolive (CL) Position Lowered by Northern Oak Wealth Management Inc.” was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/colgate-palmolive-cl-position-lowered-by-northern-oak-wealth-management-inc/1816707.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.